Xuping Xie to Female
This is a "connection" page, showing publications Xuping Xie has written about Female.
Connection Strength
0.036
-
Small Molecules and Antibodies for Zika Therapy. J Infect Dis. 2017 12 16; 216(suppl_10):S945-S950.
Score: 0.010
-
Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease. Cell Host Microbe. 2021 07 14; 29(7):1151-1161.e5.
Score: 0.003
-
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains. Nature. 2021 08; 596(7870):103-108.
Score: 0.003
-
Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants. Nature. 2021 07; 595(7869):718-723.
Score: 0.003
-
Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis. Nature. 2021 03; 591(7849):293-299.
Score: 0.003
-
Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape. Nat Commun. 2021 01 20; 12(1):469.
Score: 0.003
-
Occupational Factors Causing Pain Among Nurses in Mainland China. Med Sci Monit. 2019 Feb 08; 25:1071-1077.
Score: 0.003
-
Using a Virion Assembly-Defective Dengue Virus as a Vaccine Approach. J Virol. 2018 11 01; 92(21).
Score: 0.003
-
Characterization of a candidate tetravalent vaccine based on 2'-O-methyltransferase mutants. PLoS One. 2018; 13(1):e0189262.
Score: 0.002
-
A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damage. Nat Commun. 2017 09 22; 8(1):676.
Score: 0.002